1 / 17

Differences and similarities between Guideline adaptation and development

Clinical Practice Guidelines: adaptation versus de novo development.<br>Part of a workshop presented in Tunisia INA Sante

yasser3amer
Download Presentation

Differences and similarities between Guideline adaptation and development

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CPG Development (de novo) vs. Adaptation Dr. Yasser Sami Amer MBBCh, MS Ped, MS HCI, CPHQ, FISQua CPG Methodologist, CPG Steering Committee, CPG Unit, Quality Management Department, King Saud University Medical City CPG Adaptation Workshop, INA Santé, Tunisia, 24-26 May 2016

  2. What makes a trustworthy CPG?

  3. Standards for trustworthy CPGs

  4. CPG development (de novo)

  5. CPG development methodologies

  6. What is CPG adaptation? “Guideline adaptation is the systematic approach to the endorsement and/or modification of a guideline(s) produced in one cultural and organizational setting for application in a different context. Where high quality guidelines are already available, adaptation may be used as an alternative to de novo guideline development to customize the existing guideline to the needs of local users.” The ADAPTE Collaboration (2006-2010)

  7. Why CPG Adaptation? • Proper development and updating of high-quality CPGs require substantial time, expertise and resources.  • Need of HCOs to standardize health policies and practices to promote optimal EBHC. • Pressure on HCOs to produce CPGs rapidly, to ensure that medical practice is consistent with current, emerging medical knowledge. This work is often done with limited resources.

  8. The ADAPTE postulates that . . . . . . . . .existing high quality CPGs as a resource may be an alternative to de novo development to reduce duplication of effort, enhance efficiency, and promote local uptake of quality CPG recommendations.

  9. The ADAPTE . . . • The ADAPTE Collaboration was born of two independent groups focusing on guideline adaptation: the ADAPTE group and the Practice Guideline Evaluation and Adaptation Cycle (PGEAC). • In 2010, following the development of the ADAPTE Manual and Resource Toolkit &its evaluation, the group asked the G-I-N to ensure the continuity of the work in the area &to make these resources available to the international community through the G-I-N Adaptation Working Group was established.

  10. Main differences Develop vs. ADAPTE

  11. Summary of the ADAPTE

  12. 3 Phases, 9 Modules, 23 Steps

  13. ADAPTE & AGREE II • Both are validated CPG appraisal tools.

  14. G-I-N Adaptation Working Group

  15. NajouaMlika-Cabanne, MD, PhD Najoua was born in Tunisia and graduated from the Sousse Medical Faculty in 1982. Deputy head of the GPGs Department at the HAS (French National Authority for Health): in charge of various aspects of CPGs’ development for over 10 years. Member of the G-I-N Executive Committee; Board of Trustees 2003-2010; Honorary Patron of the G-I-N 2010, Co-chair of the International Working Group on Evidence Tables, & Co-editor the G-I-N newsletter (enGINe). Active member/ contributor in ISQua, ADAPTE, G-I-N. Died on 7thNovember 2011. http://www.g-i-n.net/about-g-i-n/trustees-bio/previous-trustees/najoua-mlika-cabanne/?searchterm=najoua%20mlika

  16. Dr. Yasser Sami Amer QMD, CPGC, KSUMC yasser3amer@yahoo.com

More Related